When it comes to reduction of weight-related issues like diabetes, heart disease risks and metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as nonalcoholic fatty liver disease (NAFLD), bariatric surgery far outpaces GLP-1s in reduction, and often removal, of these risks
So if someone has endometriosis plus insulin resistance, metabolic syndrome, central adiposity, maybe they have A-P-C-O-S overlap
GLP1 receptor agonists (e.g., semaglutide) and dual GLP1 receptor agonists/GIP agonists (e.g., tirzepatide) have been shown to significantly reduce weight in patients with obesity, with and without type 2 diabetes
& Mettenleiter, T
Multiple doctors recommend B-12 injections for anyone with a deficiency in the vitamin
Have you tried Rootcology protein powder